Tracing of Patients Lost to Follow-up and HIV Transmission: Mathematical Modeling Study Based on 2 Large ART Programs in Malawi

Objective:Treatment as prevention depends on retaining HIV-infected patients in care. We investigated the effect on HIV transmission of bringing patients lost to follow-up (LTFU) back into care. Design:Mathematical model. Methods:Stochastic mathematical model of cohorts of 1000 HIV-infected patients on antiretroviral therapy, based on the data from 2 clinics in Lilongwe, Malawi. We calculated cohort viral load (sum of individual mean viral loads each year) and used a mathematical relationship between viral load and transmission probability to estimate the number of new HIV infections. We simulated 4 scenarios: “no LTFU” (all patients stay in care), “no tracing” (patients LTFU are not traced), “immediate tracing” (after missed clinic appointment), and “delayed tracing” (after 6 months). Results:About 440 of 1000 patients were LTFU over 5 years. Cohort viral loads (million copies/mL per 1000 patients) were 3.7 [95% prediction interval (PrI), 2.9–4.9] for no LTFU, 8.6 (95% PrI, 7.3–10.0) for no tracing, 7.7 (95% PrI, 6.2–9.1) for immediate, and 8.0 (95% PrI, 6.7–9.5) for delayed tracing. Comparing no LTFU with no tracing, the number of new infections increased from 33 (95% PrI, 29–38) to 54 (95% PrI, 47–60) per 1000 patients. Immediate tracing prevented 3.6 (95% PrI, −3.3 to 12.8) and delayed tracing 2.5 (95% PrI, −5.8 to 11.1) new infections per 1000. Immediate tracing was more efficient than delayed tracing: to 116 and 142 tracing efforts, respectively, were needed prevent 1 new infection. Conclusions:Tracing of patients LTFU enhances the preventive effect of antiretroviral therapy, but the number of transmissions prevented is small.

[1]  A. Harries,et al.  Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2]  M. Egger,et al.  Are They Really Lost? “True” Status and Reasons for Treatment Discontinuation among HIV Infected Patients on Antiretroviral Therapy Considered Lost to Follow Up in Urban Malawi , 2013, PloS one.

[3]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[4]  B. Stilwell,et al.  Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .

[5]  F. Neuhann,et al.  The Lighthouse: a centre for comprehensive HIV / AIDS treatment and care in Malawi. Case study. , 2004 .

[6]  M. Egger,et al.  Mortality and loss to follow-up in the first year of ART: Malawi national ART programme , 2012, AIDS.

[7]  A. Harries,et al.  Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  R. Walensky,et al.  Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Peter Piot,et al.  Joint United Nations Program on HIV/AIDS (UNAIDS) , 1997 .

[10]  Trevor F Peter,et al.  Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study , 2011, The Lancet.

[11]  A. Jahn,et al.  Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi , 2009, Tropical doctor.

[12]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[13]  Colin Mathers,et al.  Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality , 2009, PLoS medicine.

[14]  D. Gareta,et al.  Integrated tuberculosis and HIV care in a resource‐limited setting: experience from the Martin Preuss centre, Malawi , 2011, Tropical medicine & international health : TM & IH.

[15]  D. Gareta,et al.  Early active follow‐up of patients on antiretroviral therapy (ART) who are lost to follow‐up: the ‘Back‐to‐Care’ project in Lilongwe, Malawi , 2010, Tropical medicine & international health : TM & IH.

[16]  Sydney Rosen,et al.  Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.

[17]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[18]  T. Reid,et al.  Implementation and outcomes of an active defaulter tracing system for HIV, prevention of mother to child transmission of HIV (PMTCT), and TB patients in Kibera, Nairobi, Kenya. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  HOMAS,et al.  VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 , 2000 .

[20]  Thomas Gsponer,et al.  Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis , 2012, AIDS.

[21]  Nello Blaser,et al.  Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study , 2013, AIDS.

[22]  J. Stringer,et al.  Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study , 2013, PloS one.

[23]  E. Vittinghoff,et al.  Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco , 2010, PloS one.

[24]  Matthew G Law,et al.  Relation between HIV viral load and infectiousness: a model-based analysis , 2008, The Lancet.